- Home
- SNTI vs AFJK Comparison
SNTI vs AFJK Comparison
Compare SNTI & AFJK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- AFJK
- Stock Information
- Founded
- SNTI 2016
- AFJK 2023
- Country
- SNTI United States
- AFJK United States
- Employees
- SNTI N/A
- AFJK N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- AFJK
- Sector
- SNTI Health Care
- AFJK
- Exchange
- SNTI Nasdaq
- AFJK NYSE
- Market Cap
- SNTI 85.3M
- AFJK 68.3M
- IPO Year
- SNTI N/A
- AFJK 2023
- Fundamental
- Price
- SNTI $2.26
- AFJK N/A
- Analyst Decision
- SNTI Strong Buy
- AFJK
- Analyst Count
- SNTI 2
- AFJK 0
- Target Price
- SNTI $8.50
- AFJK N/A
- AVG Volume (30 Days)
- SNTI 385.8K
- AFJK 1.8K
- Earning Date
- SNTI 08-12-2025
- AFJK 01-01-0001
- Dividend Yield
- SNTI N/A
- AFJK N/A
- EPS Growth
- SNTI N/A
- AFJK N/A
- EPS
- SNTI N/A
- AFJK 0.23
- Revenue
- SNTI N/A
- AFJK N/A
- Revenue This Year
- SNTI N/A
- AFJK N/A
- Revenue Next Year
- SNTI $150.00
- AFJK N/A
- P/E Ratio
- SNTI N/A
- AFJK $48.34
- Revenue Growth
- SNTI N/A
- AFJK N/A
- 52 Week Low
- SNTI $1.52
- AFJK $10.24
- 52 Week High
- SNTI $16.94
- AFJK $11.20
- Technical
- Relative Strength Index (RSI)
- SNTI 37.88
- AFJK N/A
- Support Level
- SNTI $2.05
- AFJK N/A
- Resistance Level
- SNTI $2.35
- AFJK N/A
- Average True Range (ATR)
- SNTI 0.30
- AFJK 0.00
- MACD
- SNTI 0.00
- AFJK 0.00
- Stochastic Oscillator
- SNTI 20.00
- AFJK 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About AFJK AIMEI HEALTH TECHNOLOGY CO LTD
Aimei Health Technology Co Ltd is a blank check company.